Whitepaper: Evaluating the impact of error rate on productivity and cost savings in synthetic DNA fragments
Posted: 16 September 2019 | Thermo Fisher Scientific | No comments yet
Surveys and interviews with researchers revealed that less hands on time, an easy-to-use method and a high cloning success rate are important factors to consider to evaluate technologies and vendors for synthetic DNA. To address these needs, we developed Invitrogen™ GeneArt™ High-Q Strings™ DNA Fragments.
These DNA fragments are made using our cutting-edge microchip DNA synthesis platform, resulting in superior accuracy for uncloned DNA fragments. To demonstrate the benefits of this technology, we compared these GeneArt fragments to DNA fragments from two different suppliers and found that the GeneArt technology brings about a 60 percent reduction in cloning effort with up to 30 percent cost savings.
Related content from this organisation
- CRISPR-Cas9-based gene dropout screens: a powerful platform for drug discovery
- The diversity of synthetic biology applications
- Under the microscope: Leveraging CRISPR libraries for target discovery
- Application note: Improving and simplifying the design of knock-in experiments using the TrueDesign Genome Editor
- Better therapeutic antibodies by design
Related topics
DNA, Informatics, Research & Development, Screening, Sequencing, Technology
Related organisations
Thermo Fisher Scientific